Newormics
MENUMENU
  • Products
    • All Products
    • vivoChip-2x
    • vivoCube
    • Accessories
    • vivoCube Rental
  • Services
    • Neurotoxicity Assessment
  • Technology
    • FAQs
    • Publications
    • Video Gallery
    • Application Notes
    • Customer Applications
    • Webinars
  • Company
    • About Us
    • Careers
    • Customer Testimonials
  • News
  • Contact
August 20, 2020 adamlaing

test page

Archives

  • May 2021
  • August 2020
  • July 2020
  • March 2020
  • October 2019
  • August 2019
  • July 2019
  • June 2019
  • October 2018

Meta

  • Log in

Products
  • All Products
  • vivoChip-2x
  • vivoCube
  • Accessories
  • vivoCube Rental

Services
  • Neurotoxicity Assessment

Technology
  • FAQs
  • Publications
  • Video Gallery
  • Application Notes
  • Customer Applications
  • Webinars

Company
  • About Us
  • Careers
  • Customer Testimonials
  • FCOI
  • News

    Contact

    Newormics LLC
    3303 Northland Drive
    Suite 308
    Austin, TX, 78731

    support@newormics.com
    • Facebook link
    • Twitter link
    • Linkedin link

    © 2021 Newormics LLC. All rights reserved.

    Zelle Lite developed by ThemeIsle
    Nicholas Chavez


    Nicholas Chavez graduated with a Bachelors in Computational Biomedical Engineering from The University of Texas at Austin. After spending time as a software engineer in the tech industry, he has returned to the biotech field in the capacity of a bioimaging software engineer for Newormics. Here, he aids the company with the automation of data acquisition and processing as well as the development of embedded systems and full stack processes.

    ..

    Adam Laing, PhD


    Dr. Adam Laing is a molecular and cellular biologist educated at the University of Edinburgh, and leads the Research and Development activities of Newormics. He is responsible for testing and characterizing the new devices and imaging methods, and development of toxicology and drug screening assays in C. elegans as well as tissue organoids.

    ..

    Adela Ben-Yakar, PhD

    A professor with dual appointments in Mechanical Engineering and Biomedical Engineering at The University of Texas at Austin, Dr Ben-Yakar’s research focuses on the creation of imaging technologies and novel laser surgery with high precision. Educated at Stanford and the Technion in Israel, with post-doctoral study at Harvard, and using her NIH Director’s Transformative Research Award, Dr Ben-Yakar began the research that has culminated in the launch of Newormics, LLC

    ..

    Contact us

    Contact us for more information on our products and services.

    vivoCube rental information request
    Evan Hegarty, MSE


    Evan Hegarty, co-founder, received his M.S. in Mechanical Engineering at The University of Texas at Austin while developing the technology and IP that lead to the launch of Newormics, LLC. As the Director of Manufacturing and Product development, and Principal Investigator of NIH SBIR grants at Newormics, Evan is responsible for development of all chip and system designs, creating production schedules, optimizing production methods, managing team members, identifying customer needs, developing future products, and reinforcing GLP and GMP.

    ..

    Jacob Moore, PhD


    Jacob Moore completed his master’s and PhD in mechanical engineering at the University of Texas at Austin before joining the Newormics team. From his experimental research in the gas turbine industry, he developed a hands-on expertise in thermal/fluids systems that he is applying to chip and system designs. In addition, he is using his automated laboratory measurement experience to mature automation designs using Newormics technology.

    ..

    Gina Lento, PhD


    Dr. Lento is a serial COO/VPO executive for life science startups with broad skills in pharmaceuticals, medical devices, and diagnostics. With a unique background of equal parts government, public and private sector service, Dr. Lento holds a PhD in Biochemistry and additional credentials in Drug Evaluation, Pharmaceutical Sciences, and Corporate Governance.

    ..